Fibromuscular dysplasia classification: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(32 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Fibromuscular dysplasia}}{{Mohsen}}
{{Fibromuscular dysplasia}}


{{CMG}}; {{AE}}  
{{CMG}}; {{AE}} {{M.B}}
==Overview==
==Overview==
There is no established system for the classification of [disease name].
The classification system for fibromuscular dysplasia (FMD) was first according to the arterial layer involved. ([[tunica intima]], [[tunica media]] , or [[adventitia]]) . However, with use of transluminal [[percutaneous]] [[angioplasty]] (TPA) for treatment of FMD lesions and its preference rather than surgery, the obtaining of pathological specimens are restricted. Thus, today, FMD is a disease diagnosed radiographically and histopathological classification has been replaced by the [[Arteriography|arteriographic]] findings.


OR
==Classification==
 
Fibromuscular dysplasia may be classified according to [[Angiogram|angiographic]] findings or [[histological]] characteristics, as below:
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
 
OR
 
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3].
[Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
 
OR
 
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
 
OR


If the staging system involves specific and characteristic findings and features:
'''Angiografic classification:'''  <ref>Persu A, Touze E, Mousseaux E, Barral X, Joffre F, Plouin PF. Diagnosis
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
and management of fibromuscular dysplasia: an expert consensus. Eur J
Clin Invest. 2012;42:338–347</ref>
*Multifocal FMD
**With [[Angiogram|angiographic]] appearance of a "string of beads" due to multiple areas of [[stenosis]] and [[dilatation]](image?) this subtype corresponds pathologically to medial fibroplasia.
*Focal FMD
**This form is less common , and it has the [[angiographic]] appearance of a "circumferential or tubular stenosis" and corresponds pathologically to intimal fibroplasia, medial hyperplasia and periarterial hyperplasia are histologic types that may also have a focal appearance.


OR
It has been shown that these two different angiographic subtypes of FMD (multifocal and focal) have different phenotypic presentations and natural history.<ref>{{Cite journal
| author = [[Sebastien Savard]], [[Olivier Steichen]], [[Arshid Azarine]], [[Michel Azizi]], [[Xavier Jeunemaitre]] & [[Pierre-Francois Plouin]]
| title = Association between 2 angiographic subtypes of renal artery fibromuscular dysplasia and clinical characteristics
| journal = [[Circulation]]
| volume = 126
| issue = 25
| pages = 3062–3069
| year = 2012
| month = December
| doi = 10.1161/CIRCULATIONAHA.112.117499
| pmid = 23155180
}}</ref>


The staging of [malignancy name] is based on the [staging system].
=== Histological classification: ===
In this classification system, FMD is categorized according to the arterial layer involved.


OR
'''Medial dysplasia'''
*Medial [[dysplasia]] is the most common type of FMD and is accounting for more than eighty percent of fibromuscular lesions.
*Medial FMD is further subdivided into three subtypes: '''medial fibroplasia, perimedial fibroplasia, and medial hyperplasia.'''
**'''Medial [[fibroplasia]]''' microscopically is accompanied by alternating areas of thinned and thickened [[Anatomical terms of location|media]]. Thickened area are fibromuscular ridges containing [[collagen]] as well thinned areas are due to smooth muscle and [[internal elastic lamina]] loss with resultant arterial [[stenosis]] alternating with [[dilatation]]. This subtype corresponds angiographically to the classic "string of beads" appearance.
**'''''Perimedial fibroplasia''''' is associated with [[collagen]] deposition  in the outer half of the media; and medial hyperplasia, in which there is true smooth muscle [[hyperplasia]] without significant fibrosis as well as collagen deposition<ref name="pmid1131001">{{cite journal |vauthors=Stanley JC, Gewertz BL, Bove EL, Sottiurai V, Fry WJ |title=Arterial fibrodysplasia. Histopathologic character and current etiologic concepts |journal=Arch Surg |volume=110 |issue=5 |pages=561–6 |date=May 1975 |pmid=1131001 |doi= |url=}}</ref>


There is no established system for the staging of [malignancy name].
==== '''Intimal fibroplasia''' ====
*Intimal fibroplasia is caused by circumferential or eccentric deposition of collagen in the intima. The [[internal elastic lamina]] may be intact, fragmented, or duplicated. There is no inflammatory or [[lipid]] component. This subtype  corresponds angiografically to Focal FMD.


==Classification==
==== Adventitial  disease ====
fghjkjjhfrsdxck8i7tg uythci75hygf  loi[ ;
*Adventitial  disease, a rare manifestation of FMD, is caused by replacement of [[fibrous tissue]] of [[Adventitia|adventitia]] with dense [[collagen]], collagen deposition may extend into the periarterial tissue, with accompanying [[inflammation]] and focal [[Infiltration (medical)|infiltration]] of [[lymphocytes]].
*There is no established system for the classification of [disease name].
OR
*[Disease name] may be classified according to [classification method] into [number] subtypes/groups:
**[Group1]
**[Group2]
**[Group3]
**[Group4]
OR
*[Disease name] may be classified into [large number > 6] subtypes based on:
**[Classification method 1]
**[Classification method 2]
**[Classification method 3]
*[Disease name] may be classified into several subtypes based on:
**[Classification method 1]
**[Classification method 2]
**[Classification method 3]
OR
*Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
*If the staging system involves specific and characteristic findings and features:
*According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
*The staging of [malignancy name] is based on the [staging system].
OR
*There is no established system for the staging of [malignancy name].


==References==
==References==

Latest revision as of 22:16, 19 August 2018

Fibromuscular dysplasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fibromuscular dysplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiorgram

X-ray

CT

MRI

Arteriography

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Management Guidelines

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

ASA/ACCF/AHA Guideline Recommendations

Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries

Case Studies

Case #1

Fibromuscular dysplasia classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fibromuscular dysplasia classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fibromuscular dysplasia classification

CDC on Fibromuscular dysplasia classification

Fibromuscular dysplasia classification in the news

Blogs on Fibromuscular dysplasia classification

Directions to Hospitals Treating Fibromuscular dysplasia

Risk calculators and risk factors for Fibromuscular dysplasia classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohsen Basiri M.D.

Overview

The classification system for fibromuscular dysplasia (FMD) was first according to the arterial layer involved. (tunica intima, tunica media , or adventitia) . However, with use of transluminal percutaneous angioplasty (TPA) for treatment of FMD lesions and its preference rather than surgery, the obtaining of pathological specimens are restricted. Thus, today, FMD is a disease diagnosed radiographically and histopathological classification has been replaced by the arteriographic findings.

Classification

Fibromuscular dysplasia may be classified according to angiographic findings or histological characteristics, as below:

Angiografic classification: [1]

  • Multifocal FMD
    • With angiographic appearance of a "string of beads" due to multiple areas of stenosis and dilatation(image?) this subtype corresponds pathologically to medial fibroplasia.
  • Focal FMD
    • This form is less common , and it has the angiographic appearance of a "circumferential or tubular stenosis" and corresponds pathologically to intimal fibroplasia, medial hyperplasia and periarterial hyperplasia are histologic types that may also have a focal appearance.

It has been shown that these two different angiographic subtypes of FMD (multifocal and focal) have different phenotypic presentations and natural history.[2]

Histological classification:

In this classification system, FMD is categorized according to the arterial layer involved.

Medial dysplasia

  • Medial dysplasia is the most common type of FMD and is accounting for more than eighty percent of fibromuscular lesions.
  • Medial FMD is further subdivided into three subtypes: medial fibroplasia, perimedial fibroplasia, and medial hyperplasia.
    • Medial fibroplasia microscopically is accompanied by alternating areas of thinned and thickened media. Thickened area are fibromuscular ridges containing collagen as well thinned areas are due to smooth muscle and internal elastic lamina loss with resultant arterial stenosis alternating with dilatation. This subtype corresponds angiographically to the classic "string of beads" appearance.
    • Perimedial fibroplasia is associated with collagen deposition in the outer half of the media; and medial hyperplasia, in which there is true smooth muscle hyperplasia without significant fibrosis as well as collagen deposition[3]

Intimal fibroplasia

  • Intimal fibroplasia is caused by circumferential or eccentric deposition of collagen in the intima. The internal elastic lamina may be intact, fragmented, or duplicated. There is no inflammatory or lipid component. This subtype corresponds angiografically to Focal FMD.

Adventitial disease

References

  1. Persu A, Touze E, Mousseaux E, Barral X, Joffre F, Plouin PF. Diagnosis and management of fibromuscular dysplasia: an expert consensus. Eur J Clin Invest. 2012;42:338–347
  2. Sebastien Savard, Olivier Steichen, Arshid Azarine, Michel Azizi, Xavier Jeunemaitre & Pierre-Francois Plouin (2012). "Association between 2 angiographic subtypes of renal artery fibromuscular dysplasia and clinical characteristics". Circulation. 126 (25): 3062–3069. doi:10.1161/CIRCULATIONAHA.112.117499. PMID 23155180. Unknown parameter |month= ignored (help)
  3. Stanley JC, Gewertz BL, Bove EL, Sottiurai V, Fry WJ (May 1975). "Arterial fibrodysplasia. Histopathologic character and current etiologic concepts". Arch Surg. 110 (5): 561–6. PMID 1131001.

Template:WH Template:WS